Cargando…
Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry
Diabetic kidney disease (DKD) is the major cause of end stage renal disease in patients with type 2 diabetes mellitus (T2DM). The subtle metabolic changes in plasma and cerebrospinal fluid (CSF) might precede the development of DKD by years. In this longitudinal study, CSF and plasma samples were co...
Autores principales: | Lin, Huan-Tang, Cheng, Mei-Ling, Lo, Chi-Jen, Lin, Gigin, Liu, Fu-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689120/ https://www.ncbi.nlm.nih.gov/pubmed/36359470 http://dx.doi.org/10.3390/diagnostics12112626 |
Ejemplares similares
-
Exploring the aging process of cognitively healthy adults by analyzing cerebrospinal fluid metabolomics using liquid chromatography-tandem mass spectrometry
por: Liu, Fu-Chao, et al.
Publicado: (2023) -
(1)H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy
por: Lin, Huan-Tang, et al.
Publicado: (2019) -
Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach
por: Yang, Hao, et al.
Publicado: (2022) -
Quantification of 4-Methylimidazol in NMRI Mice Plasma and Cerebrospinal Fluid (CSF) by Using Liquid Chromatography Tandem Mass Spectrometry
por: Mehri, Fereshteh, et al.
Publicado: (2020) -
A Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneously Determining Meropenem and Linezolid in Blood and Cerebrospinal Fluid
por: Berska, Joanna, et al.
Publicado: (2024)